Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Ray Furey - Executive Vice President, General Counsel and Corporate Secretary Raul Rodriguez - President and Chief Executive Officer Dave Santos - Chief Commercial Officer Francois Di Trapani - Senior Vice President of Medical Affairs Dean Schorno - Chief Financial Officer Conference Call Participants Yigal Nochomovitz - Citigroup Kristen Kluska - Cantor Fitzgerald Kalpit Patel - B. Riley ...